Gilles Brisson

Gilles Brisson currently works at Laboratoire Français du Fractionnement et des Biotechnologies, as Director and Financière Verdi Iii, as Member-Supervisory Board from 2018.
Mr. Brisson also formerly worked at Ethypharm SAS, as Chairman-Supervisory Board from 2009 to 2016, Aventis Pharma SARL, as Chairman-Supervisory Board, Mauna Kea Technologies SA, as Chairman from 2012 to 2014, Bioring SA, as Chairman, Mutabilis Holding SAS, as Chairman, Innate Pharma SA, as Member-Supervisory Board from 2016 to 2025, Grupo Carso SAB de CV, as Member-Supervisory Board, Sanofi-Aventis Europe SAS, as SVP-European Commercial Operations, and Rhone Poulenc Rorer, as Senior Vice President-Corporate Development.
Mr. Brisson received his undergraduate degree from École des Hautes Études Commerciales de Paris.